Early-bird rates available until Friday 29 January!
are limited, so book early to avoid disappointment.
The symposium will provide a unique platform for
cross-collaboration and discussion between industry, public sector, academia
and regulators and focus on the latest thinking and opportunities arising from
the new Biological Medicines. The goal is to identify potential solutions,
future work programmes and productive collaborations that overcome the key regulatory
challenges and facilitate accelerated access to safe and effective biologicals.
We are delighted that Professor Dame Sally Davies, Chief Medical Officer, will
be giving a keynote introductory address with
further international and leading experts presenting on the following themes:
Antibodies the future of biological therapies
pathology and Precision Medicines the importance of getting it right!
the Vaccine pipeline flowing
- Advanced Therapies delivering
attendance of 200+ delegates from the biological medicines sector in the
UK and abroad.
about the latest strategic and technical developments taking place in
biological medicines and gain insight into the regulatory challenge that they
and take the opportunity to meet key contacts, build relationships and
shape the future of the new biological medicines regulation
There will also
be the opportunity to pose questions, participate in technical discussions and
to network with peers. The symposium
networking dinner (included in ticket prices) will be held on the evening of
the 17th May 2016.